%0 Journal Article
%T The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cells
%A Alshad S. Lalani
%A Andrew Poklepovic
%A Francesca Avogadri-Connors
%A Jane L. Roberts
%A Laurence Booth
%A Paul Dent
%A Peter Samuel
%A Richard E. Cutler
%J Archive of "Cancer Biology & Therapy".
%D 2018
%R 10.1080/15384047.2018.1436024
%K Autophagy
%K neratinib
%K niraparib
%K receptor tyrosine kinase
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927661/